BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24603659)

  • 21. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance.
    Kozak CA; Chakraborti A
    Virology; 1996 Nov; 225(2):300-5. PubMed ID: 8918916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of endogenous gammaretroviruses and variants of the Fv1 restriction gene in individual mouse strains and strain subgroups.
    Skorski M; Bamunusinghe D; Liu Q; Shaffer E; Kozak CA
    PLoS One; 2019; 14(7):e0219576. PubMed ID: 31291374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fv1, the mouse retrovirus resistance gene.
    Stoye JP
    Rev Sci Tech; 1998 Apr; 17(1):269-77. PubMed ID: 9638816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein.
    Ohkura S; Goldstone DC; Yap MW; Holden-Dye K; Taylor IA; Stoye JP
    PLoS Pathog; 2011 Mar; 7(3):e1002011. PubMed ID: 21483490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of functional and sequence variants of the mammalian XPR1 receptor for mouse xenotropic gammaretroviruses and the human-derived retrovirus XMRV.
    Yan Y; Liu Q; Wollenberg K; Martin C; Buckler-White A; Kozak CA
    J Virol; 2010 Nov; 84(22):11970-80. PubMed ID: 20844050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription.
    Passerini LD; Keckesova Z; Towers GJ
    J Virol; 2006 Mar; 80(5):2100-5. PubMed ID: 16474118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning of a new murine endogenous retrovirus, MuERV-L, with strong similarity to the human HERV-L element and with a gag coding sequence closely related to the Fv1 restriction gene.
    Bénit L; De Parseval N; Casella JF; Callebaut I; Cordonnier A; Heidmann T
    J Virol; 1997 Jul; 71(7):5652-7. PubMed ID: 9188643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Megabat-Favored, CA-Dependent Susceptibility to Retrovirus Infection.
    Ohkura S; Horie M; Shimizu M; Nakagawa S; Osanai H; Miyagawa Y; Morita R
    J Virol; 2023 Mar; 97(3):e0180322. PubMed ID: 36779757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular phylogeny of Fv1.
    Qi CF; Bonhomme F; Buckler-White A; Buckler C; Orth A; Lander MR; Chattopadhyay SK; Morse HC
    Mamm Genome; 1998 Dec; 9(12):1049-55. PubMed ID: 9880676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restriction of multiple divergent retroviruses by Lv1 and Ref1.
    Hatziioannou T; Cowan S; Goff SP; Bieniasz PD; Towers GJ
    EMBO J; 2003 Feb; 22(3):385-94. PubMed ID: 12554640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.
    Maillard PV; Reynard S; Serhan F; Turelli P; Trono D
    PLoS Pathog; 2007 Dec; 3(12):e200. PubMed ID: 18166079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
    Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
    J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
    Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
    J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRIM5α Degradation via Autophagy Is Not Required for Retroviral Restriction.
    Imam S; Talley S; Nelson RS; Dharan A; O'Connor C; Hope TJ; Campbell EM
    J Virol; 2016 Jan; 90(7):3400-10. PubMed ID: 26764007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Retroviral restriction factors : from Fv1 to TRIM5α].
    Cissé A; Darbandi-Tehrani K; Derache A; El Houry S; Marlin R; Pernet O; Nisole S
    Virologie (Montrouge); 2006 Apr; 10(2):119-127. PubMed ID: 34679269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fv1-like restriction of N-tropic replication-competent murine leukaemia viruses in mCAT-1-expressing human cells.
    Aagaard L; Mikkelsen JG; Warming S; Duch M; Pedersen FS
    J Gen Virol; 2002 Feb; 83(Pt 2):439-442. PubMed ID: 11807237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a transient assay for studying the genetic determinants of Fv1 restriction.
    Bock M; Bishop KN; Towers G; Stoye JP
    J Virol; 2000 Aug; 74(16):7422-30. PubMed ID: 10906195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral restriction factors in mice.
    Nair S; Rein A
    Virus Res; 2014 Nov; 193():130-4. PubMed ID: 25018022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SERINC5 Potently Restricts Retrovirus Infection
    Timilsina U; Umthong S; Lynch B; Stablewski A; Stavrou S
    mBio; 2020 Jul; 11(4):. PubMed ID: 32665269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deaminase-Dead Mouse APOBEC3 Is an
    Stavrou S; Zhao W; Blouch K; Ross SR
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.